A. Bala´zs et al. / Steroids 69 (2004) 271–277
273
C18H3), 0.68−2.43 (m, 20H, ring protons), 2.62 (m,
2.2.5. Isopropyl 2β-hydroxy-17-keto-5α-androstan-
3α-carboxylate (10c)
1H, C2H), 3.63 (s, 3H, –OCH3), 4.38 (m, 1H, C3H);
13C NMR (δ, CDCl3): 11.87, 13.77, 20.20, 21.67,
27.75, 30.66, 31.47, 33.31, 34.74, 35.13, 35.77, 36.45,
39.05, 44.64, 47.75, 51.33, 51.47, 54.6, 65.89, 175.13,
221.35; MS (m/z/relative intensity): 348/64 [M+], 330/23,
271/25, 218/63, 147/40, 105/100; IR (KBr, ν [cm−1]):
White powder (isolated yield: 315 mg, 84%), mp =
174 ◦C; [␣]D = 112 (c = 1 in chloroform); TLC: Rf = 0.6
[ethyl acetate/hexane (2:3) as eluting solvent]; 1H NMR (δ,
CDCl3): 0.67 (m, 1H,), 0.82 (s, 3H, C18H3), 1.01 (s, 3H,
C19H3), 0.78–2.44 (m, ring protons), 1.19 (d, J = 6.1 Hz,
3H, –CH(CH3)2), 1.22 (d, J = 6.1 Hz, 3H, –CH(CH3)2),
2.65 (m, 1H, C3H), 4.39 (q, 1H, J = 3.1 Hz, C2H), 5.0
(septet, 1H, J = 6.1 Hz); 13C NMR (δ, CDCl3): 13.8, 14.64,
20.09, 21.66, 21.71, 21.79, 26.05, 27.99, 30.61, 31.48,
34.38, 35.72, 35.77, 43.34, 42.54, 46.76, 47.78, 51.29,
55.26, 67.54, 67.94, 173.25, 221.25; MS (m/z/relative in-
tensity): 376/1 [M+], 335/3, 316/8, 231/12, 213/10, 173/11,
149/15, 121/22, 107/34, 93/48, 67/70, 55/100; IR (KBr, ν
=
1736 (C O).
2.2.2. Ethyl 3α-hydroxy-17-keto-5α-androstan-
2β-carboxylate (7b)
White powder (isolated yield: 307 mg, 85%), mp =
119 ◦C; [␣]D = 60 (c = 1 in chloroform); TLC: Rf = 0.42
[ethyl acetate/hexane (2:3) as eluting solvent]; 1H NMR
(δ, CDCl3): 0.68 (s, 3H, C19H3), 0.89 (s, 3H, C18H3),
0.94–2.15 (m, 20H, ring protons), 1.24 (t, J = 7 Hz, 3H,
–OCH2CH3), 2.6 (m, 1H, C2H), 4.14 (q, J = 7 Hz, 2H,
–OCH2CH3), 4.42 (m, 1H, C3H); 13C NMR (δ, CDCl3):
12.06, 13.8, 14.1, 20.16, 21.68, 27.75, 30.66, 31.48, 33.36,
34.75, 35.14, 35.77, 36.5, 39.06, 44.83, 47.72, 51.36, 54.61,
60.34, 65.99, 174.58, 221.27; MS (m/z/relative intensity):
362/26 [M+], 344/30, 270/12, 218/33, 147/30, 105/100; IR
[cm−1]): 1722, 1736 (C O).
=
2.2.6. Methyl 17α-hydroxyandrostane-16α-
carboxylate (13a)
White powder (isolated yield: 94 mg, 28%), mp = 109 ◦C;
[␣]D < 1 (c = 1 in chloroform); TLC: Rf = 0.45 [ethyl ac-
etate/hexane (1:4) as eluting solvent]; 1H NMR (δ, CDCl3):
0.66 (s, 3H, C18H3), 0.76 (s, 3H, C19H3), 0.6–1.88 (m, 22H,
ring protons), 2.01 (m, 1H, C15H), 2.68 (m, 1H, C16H), 3.68
(s, 3H, –OCH3), 3.98 (d, 1H, J = 1.4 Hz, C17H); 13C NMR
(δ, CDCl3): 12.18, 16.84, 20.07, 22.13, 26.71, 28.88, 28.96,
29.25, 31.74, 32.31, 35.29, 36.23, 38.67, 45.08, 46.89, 49.64,
51.83, 52.57, 54.25, 82.8, 175.43; MS (m/z/relative inten-
sity): 334/6 [M+], 306/32, 288/19, 274/34, 256/25, 233/100,
217/48, 149/53, 109/54, 95/51; IR (KBr, ν [cm−1]): 1736
(KBr, ν [cm−1]): 1701, 1733 (C O).
=
2.2.3. Isopropyl 3α-hydroxy-17-keto-5α-androstan-
2β-carboxylate (7c)
White powder (isolated yield: 330 mg, 88%), mp =
183–187 ◦C; [␣]D = 62 (c = 1 in chloroform); TLC: Rf =
0.47 [ethyl acetate/hexane (2:3) as eluting solvent]; 1H NMR
(δ, CDCl3): 0.69 (s, 3H, C19H3), 0.82 (s, 3H, C18H3), 1.20
(d, J = 6.1 Hz, 3H, –CH(CH3)2), 1.24 (d, J = 6.1 Hz, 3H,
–CH(CH3)2), 0.91–2.45 (m, 20H, ring protons), 2.58 (m, 1H,
J1 = 8.7 Hz, J2 = 2.7 Hz, C2H), 4.39 (q, 1H, J = 2.7 Hz,
C3H), 5.0 (septet, 1H, J = 6.1 Hz, –COCH(CH3)2); 13C
NMR (δ, CDCl3): 12.19, 13.81, 20.11, 21.65, 21.68, 21.75,
27.75, 30.67, 31.49, 33.34, 34.75, 35.1, 35.78, 36.53, 39.04,
45.03, 47.76, 51.36, 54.61, 66.03, 67.70, 174.04, 221.34;
MS (m/z/relative intensity): 376/32 [M+], 358/18, 333/21,
315/100, 218/33, 147/30, 105/10; IR (KBr, ν [cm−1]):
=
(C O).
2.2.7. Ethyl 17α-hydroxyandrostane-16α-
carboxylate (13b)
White powder (isolated yield: 285 mg, 82%), mp =
113–115 ◦C; [␣]D < 1 (c = 1 in chloroform); TLC:
Rf = 0.46 [ethyl acetate/hexane (1:4) as eluting solvent];
1H NMR (δ, CDCl3): 0.66 (s, 3H, C18H3), 0.76 (s, 3H,
C19H3), 0.66–1.75 (m, 22H, ring protons), 1.21 (t, 3H,
J = 7.1 Hz, –OCH2CH3), 2.01 (m, 1H, C15H), 2.67 (dt,
1H, J1 = 8.7 Hz, J2 = 1.5 Hz, C16H), 3.98 (d, 1H, J =
1.5 Hz, C17H), 4.13 (q, 2H, J = 7.1 Hz, –OCH2CH3); 13C
NMR (δ, CDCl3): 12.18, 14.22, 16.82, 20.09, 22.13, 26.72,
28.89, 28.96, 29.25, 31.76, 35.28, 35.30, 36.27, 38.67,
45.06, 46.88, 49.63, 52.79, 54.20, 60.54, 82.78, 174.98;
MS (m/z/relative intensity): 348/1 [M+], 274/16, 256/35,
233/100, 217/31, 149/21, 109/14, 95/11; IR (KBr, ν [cm−1]):
=
1722 (C O).
2.2.4. Ethyl 2β-hydroxy-17-keto-5α-androstan-3α-
carboxylate (10b)
White powder (isolated yield: 288 mg, 80%), mp =
122–125 ◦C; [␣]D = 115 (c = 1 in chloroform); TLC: Rf =
0.54 [ethyl acetate/hexane (2:3) as eluting solvent]; 1H
NMR (δ, CDCl3): 0.83 (s, 3H, C18H3), 0.99 (s, 3H, C19H3),
0.94–2.47 (m, 20H, ring protons), 1.24 (t, J = 7 Hz, 3H,
–OCH2CH3), 2.6 (m, 1H, C2H), 4.14 (q, J = 7 Hz, 2H,
–OCH2CH3), 4.42 (m, 1H, C3H); 13C NMR (δ, CDCl3):
13.8, 14.18, 14.62, 20.09, 21.66, 26.0, 27.94, 30.55, 31.48,
34.36, 35.72, 35.76, 42.33, 42.52, 46.66, 47.78, 51.31,
55.18, 60.35, 67.91, 173.78, 221.27; MS (m/z/relative inten-
sity): 362/2 [M+], 345/5, 270/10, 231/20, 213/10, 147/18,
121/25, 107/65, 79/75, 67/80, 55/100; IR (KBr, ν [cm−1]):
=
1729 (C O).
2.2.8. Isopropyl 17α-hydroxyandrostane-16α-
carboxylate (13c)
White powder (isolated yield: 304 mg, 84%), mp =
77–83 ◦C; [␣]D < 1 (c = 1 in chloroform); TLC: Rf = 0.46
[ethyl acetate/hexane (1:4) as eluting solvent]; 1H NMR
(δ, CDCl3): 0.66 (s, 3H, C18H3), 0.77 (s, 3H, C19H3),
0.66–1.7 (m, 22H, ring protons), 1.2 (d, 6H, J = 6.4 Hz,
=
1726, 1734 (C O).